NADH and NAD+ are not two different supplements competing for your money. They are two faces of the exact same molecule, nicotinamide adenine dinucleotide, caught in different moments of the same chemical loop. NAD+ is the empty shuttle, ready to grab electrons. NADH is the loaded shuttle, carrying those electrons to your mitochondria to make energy. Understanding which one to take, and whether taking either is even the right move, comes down to one idea: your cells do not run low on NADH, they run low on total NAD. This guide breaks down the redox chemistry in plain language, walks through what the human trials actually found, and gives you a clear decision framework for NADH supplements versus NAD+ precursors.[1]
🔑 Key Takeaways
- NAD+ is the oxidized (electron-accepting) form and NADH is the reduced (electron-carrying) form of the same coenzyme, so the question "NADH or NAD+" is really about which point in the redox cycle you are supplying.[1][2]
- In healthy cells the free NAD+ to NADH ratio sits around 700 to 1, which is exactly what your cells want, because NAD+ availability, not NADH, is what limits energy reactions.[3]
- NAD is reduced (gains electrons) during glycolysis and the citric acid cycle, then oxidized (loses electrons) at the electron transport chain, answering the two most common biochemistry questions in one sentence.[2][4]
- Glycolysis produces a net 2 ATP and 2 NADH per glucose molecule, and NAD+ must be regenerated for glycolysis to keep running.[4]
- Small randomized trials of oral NADH show modest benefits for chronic fatigue and Parkinson's symptoms, but most modern longevity research targets total NAD using precursors like NMN and NR rather than NADH itself.[5][6][7][8]
NADH vs NAD+: the one-sentence answer
NAD+ and NADH are the oxidized and reduced forms of nicotinamide adenine dinucleotide, a coenzyme present in every living cell. Together they form what biochemists call a redox couple: two interconvertible versions of one molecule that constantly cycle back and forth without ever being used up.[2] NAD+ is the oxidized form, the version that is "empty" and ready to accept electrons. When it picks up two electrons and a proton it becomes NADH, the reduced, electron-loaded form. NADH then drops those electrons off at the mitochondrial electron transport chain, turns back into NAD+, and the cycle repeats.[1]
This is why framing NADH and NAD+ as rival supplements is misleading. They are the same coenzyme. What changes between them is simply whether it is carrying electrons at that instant. If you want the deeper longevity context, our overview of what NAD+ is and why it matters covers the biology in more depth, and our NAD+ benefits guide walks through the claimed effects on energy, brain function, and aging.
Is NAD oxidized or reduced?
This is the single most searched biochemistry question about NAD, and the answer is: it depends on the step, because the whole point of NAD is that it switches between the two.
- NAD+ is the oxidized form. It has lost electrons (or, more precisely, it has not yet picked any up). It acts as an oxidizing agent, pulling electrons off fuel molecules like glucose and fatty acids.[2]
- NADH is the reduced form. It has gained electrons. It acts as a reducing agent, donating those electrons to the electron transport chain to ultimately make ATP.[1][2]
A useful memory hook: in the abbreviation NADH, the extra H stands for the hydrogen (and electrons) it is carrying. NAD+ has no extra H because it is empty. So "NAD becomes reduced" when it turns into NADH, and "NADH becomes oxidized" when it turns back into NAD+. In a healthy cell most of the pool sits in the oxidized NAD+ state, ready to do work: the free cytoplasmic NAD+ to NADH ratio is estimated at roughly 700 to 1.[3]
The redox couple in plain English
Think of NAD as a fleet of delivery vans. NAD+ is an empty van leaving the depot. It picks up cargo (electrons) from your food, becoming a full van, NADH. The full van drives to the power plant (the mitochondria), unloads its cargo to generate ATP, and becomes an empty NAD+ van again. You do not have a shortage of full vans. You have a shortage of vans, period, and that is the problem aging creates.
Is NAD a product of glycolysis? (And how NADH fits in)
Strictly speaking, NAD+ is a participant in glycolysis, not a product of it, and NADH is the form that comes out the other side. Here is what actually happens. Glycolysis breaks one molecule of glucose down into two molecules of pyruvate. Along the way, at the step catalyzed by the enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH), NAD+ accepts electrons and is reduced to NADH.[2][4]
The net tally from glycolysis per glucose molecule is 2 ATP and 2 NADH, plus 2 pyruvate.[4] So the honest answer to "is NAD a product of glycolysis" is: NADH is produced, while NAD+ is consumed (regenerated later). And critically, NAD+ must be replenished for glycolysis to keep going at all. Under aerobic conditions, NADH hands its electrons to the mitochondria and is recycled back to NAD+. Under anaerobic conditions (think sprinting muscle), fermentation regenerates NAD+ by converting pyruvate to lactate.[4] Without that recycling, glycolysis would grind to a halt because there would be no empty NAD+ left to accept electrons.
Where the electrons go next
The NADH made in glycolysis (and far more of it made in the citric acid cycle inside mitochondria) ultimately delivers its electrons to respiratory complex I of the electron transport chain.[2] That electron flow powers the production of ATP, your cellular energy currency. The NAD+/NADH couple is therefore the central regulator of cellular energy metabolism, linking glycolysis in the cytoplasm to oxidative phosphorylation in the mitochondria.[2]
NADH vs NAD+ vs NADP+/NADPH: don't confuse the two couples
There is a closely related pair, NADP+ and NADPH, and mixing them up is a common mistake. The difference is a single phosphate group, but it changes the job entirely.
| Couple | Main role | Typical cellular state | What it powers |
|---|---|---|---|
| NAD+ / NADH | Energy metabolism (catabolism) | Mostly oxidized; free ratio about 700:1 toward NAD+[3] | ATP production via glycolysis, citric acid cycle, electron transport chain[2] |
| NADP+ / NADPH | Biosynthesis and antioxidant defense (anabolism) | Mostly reduced; the cell keeps NADPH dominant[3] | Fatty acid and cholesterol synthesis, regenerating glutathione[3] |
The takeaway: NAD+ is kept oxidized on purpose so it can keep accepting electrons for energy, while NADPH is kept reduced on purpose so it can keep donating electrons for building molecules and fighting oxidative stress. If you are weighing antioxidant pathways, our guide to glutathione benefits explains the system NADPH helps recharge.
Why supplement NAD at all? The age decline
Your body makes both NAD+ and NADH from precursors, chiefly forms of vitamin B3 such as niacin and nicotinamide, plus the amino acid tryptophan.[1] The problem is that total NAD levels fall as you age: some cells start burning through NAD faster than the body can replace it, and lower NAD availability has been linked to muscle weakness, metabolic issues, and cognitive decline.[1] That decline, not a specific NADH shortage, is what the supplement world is trying to address. For a practical breakdown of the options, see our ranking of NAD supplements by delivery method.
NADH supplements: what the human trials actually show
Oral NADH has been sold as a stabilized supplement (sometimes branded ENADA) for decades, mainly marketed for energy and fatigue. The clinical evidence is real but modest and dated, drawn from small trials.
Chronic fatigue syndrome
A 1999 randomized, double-blind, placebo-controlled crossover trial gave 26 patients with chronic fatigue syndrome 10 mg of oral NADH or placebo for 4 weeks each. Eight of 26 patients (31%) responded favorably to NADH compared with 2 of 26 (8%) on placebo, a roughly 23 percentage-point edge.[5] A larger 2021 randomized trial combined 20 mg of NADH with 200 mg of CoQ10 daily in 144 people with ME/CFS who completed the study, and reported a significant reduction in cognitive fatigue perception at the 4 and 8 week visits, though benefits were not uniformly sustained.[6]
Parkinson's disease
An older open-label study in 885 Parkinson's patients gave roughly half intravenous NADH and half oral NADH capsules. About 80% showed some benefit (19.3% a very good 30 to 50% improvement, 58.8% a moderate 10 to 30% improvement), and notably the oral form produced results comparable to the parenteral form.[7] These are open-label findings without a placebo control, so they should be read as preliminary, not proof.
How to read this evidence honestly
The NADH trials are small, several are decades old, and some lack placebo controls. They suggest a possible modest benefit for fatigue-related symptoms, not a proven anti-aging effect. None of them measured whether oral NADH actually raised tissue NAD levels, which is the mechanism most longevity claims rest on.
NAD+ precursors (NMN and NR): the modern alternative
Most current research does not give people NADH or NAD+ directly. Instead it gives precursors that the body converts into NAD, because raising the total NAD pool, rather than topping up the NADH side, is what cells appear to need.
- Nicotinamide mononucleotide (NMN): A 2022 randomized trial gave 250 mg/day of oral NMN to healthy volunteers for 12 weeks. Blood NAD+ levels rose significantly at 4, 8, and 12 weeks, and the dose was deemed tolerable and safe with no serious adverse events.[8]
- Nicotinamide riboside (NR): Human trials have repeatedly shown NR raises blood NAD+ and is well tolerated in healthy middle-aged and older adults.[1]
A systematic review of NAD-boosting interventions across chronic fatigue, aging, Parkinson's, and Alzheimer's concluded that NAD precursors are generally safe and well tolerated at studied doses, while emphasizing that hard clinical-outcome evidence is still developing.[9] If you want to go deeper on the precursor debate, our NAD+ vs NMN comparison covers which precursor raises NAD most efficiently.
NADH vs NAD+ vs precursors: side-by-side
| Option | What it is | Best evidence | Typical oral dose studied | Who tends to consider it |
|---|---|---|---|---|
| Oral NADH (e.g. ENADA) | The reduced, electron-carrying form | Small RCTs in CFS and open-label Parkinson's data[5][6][7] | 10 to 20 mg/day[5][6] | People chasing acute energy/fatigue relief |
| NAD+ (IV or injection) | The oxidized form delivered directly | Limited; mostly tolerability and uncontrolled reports[9] | Varies widely (clinic protocols) | People wanting a fast, clinic-administered boost |
| NMN (precursor) | Converted by the body into NAD | RCT showing raised blood NAD+, safe to 250 mg/day[8] | 250 mg/day[8] | Longevity-focused users targeting total NAD |
| NR (precursor) | Converted by the body into NAD | Multiple RCTs raising blood NAD+, well tolerated[1] | Commonly 250 to 1,000 mg/day[1] | Longevity-focused users targeting total NAD |
Which one should you take? A decision guide
This is educational framing, not medical advice. The right choice depends on your goal:
- If your goal is general healthy-aging NAD support: the bulk of human data points to a precursor (NR or NMN) rather than NADH, because precursors demonstrably raise the total NAD pool, which is the limiting factor.[1][8]
- If your goal is short-term energy or fatigue relief: oral NADH has the most direct (if modest) trial evidence for that specific symptom, particularly in chronic fatigue contexts.[5][6]
- If you want the fastest blood-level spike and have clinic access: IV or injectable NAD+ delivers the coenzyme directly, though controlled efficacy data is thin. Our explainer on NAD+ IV therapy covers the cost and trade-offs, and NAD+ injections compares the at-home route.
- If you are dosing any NAD product: review NAD+ side effects first, since flushing, nausea, and injection-site reactions are the most commonly reported issues.
Frequently Asked Questions
The bottom line
NADH and NAD+ are the same molecule in two states: NADH carries electrons, NAD+ accepts them, and they cycle endlessly in your energy metabolism. NAD is reduced during glycolysis and the citric acid cycle, then oxidized at the electron transport chain, and glycolysis nets 2 ATP and 2 NADH per glucose while constantly recycling NAD+. When people talk about "NAD decline" with age, they mean the total pool shrinks, which is why most modern research targets that pool with precursors like NMN and NR rather than dosing NADH directly. Oral NADH has a niche, evidence-backed role for fatigue symptoms, but for broad NAD support the precursors have the stronger human data. Match the form to your goal, start conservatively, and run it by a clinician first.
References
- Cleveland Clinic. NAD (Nicotinamide Adenine Dinucleotide): What It Is and Why It Matters.
- Xiao W, Wang RS, Handy DE, Loscalzo J. NAD(H) and NADP(H) Redox Couples and Cellular Energy Metabolism. Antioxid Redox Signal. 2018;28(3):251-272. PMC5737637.
- Nicotinamide adenine dinucleotide (free cytoplasmic NAD+/NADH ratio approximately 700:1; NADP+/NADPH biosynthetic role). Encyclopedic biochemistry summary.
- Chaudhry R, Varacallo M. Biochemistry, Glycolysis. StatPearls (NCBI Bookshelf), updated 2023.
- Forsyth LM, Preuss HG, MacDowell AL, et al. Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome. Ann Allergy Asthma Immunol. 1999. PMID 10071523.
- Castro-Marrero J, et al. Effect of Dietary Coenzyme Q10 Plus NADH Supplementation on Fatigue Perception and Quality of Life in ME/CFS: RCT. 2021. PMC8399248.
- Birkmayer JG, Vrecko C, Volc D, Birkmayer W. NADH, a new therapeutic approach to Parkinson's disease: comparison of oral and parenteral application. 1993. PMID 8101414.
- Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood NAD+ Levels in Healthy Subjects. 2022. PMC9036060.
- Evaluation of safety and effectiveness of NAD in different clinical conditions: a systematic review. Am J Physiol Endocrinol Metab. 2023.
